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Response of isolated Dahl rat kidney to calcium antagonists. We
studied the responses of isolated perfused kidneys from prehyperten-
sive, salt—sensitive (DS) and salt—resistant (DR) DahI rats to nitrendi-
pine or verapamil, after norepinephrine vasoconstriction. The perfusion
pressure was kept constant. Superimposition of these calcium antago-
nists upon norepinephrine increased DS GFR by 155% and DR GFR by
58% (P = 0.03), with verapamil increasing the GFR more than
nitrendipine (P = 0.02). Nitrendipine and verapamil also partially
reversed norepinephrine induced increases in renal vascular resistance,
but did not decrease vascular resistance or increase GFR in the absence
of norepinephrine. During the increase in GFR produced by calcium
antagonists, DR sodium excretion increased, but DS sodium excretion
did not. Therefore, calcium antagonists disproportionately increased
DS kidney GFR but did not correct DS kidney sodium retention. These
data raise the possibility that the DS rat kidney possesses an abnormal-
ity of cell calcium regulation affecting glomerular dynamics, and pro-
vide evidence that the renal perfusion pressure is more critical than the
GFR in adjusting DS rat sodium—excretion.
Humans with essential hypertension and the Kyoto sponta-
neously hypertensive rat (SHR) manifest abnormalities of cal-
cium metabolism [1, 2]. Calcium metabolism in the DahI
salt—sensitive (DS) and resistant (DR) rat has been character-
ized less extensively. A great deal of work has focused on the
tendency toward sodium retention by the DS rat kidney, a
characteristic thought to be important in the pathogenesis of
Dahl rat hypertension [31. We have reported that isolated
perfused kidneys from the SHR manifest exaggerated glomer-
ular circulatory responses to the calcium channel blocker,
verapamil [4]. Verapamil vasodilation largely reversed norepi-
nephrine induced increases in SHR renal vascular resistance
(RVR), and also increased the glomerular filtration rate (GFR)
to values greatly exceeding those before norepinephrine.
Wistar—Kyoto rat (WKY) kidney GFR values returned only to
baseline levels [4].
In order to determine whether or not the phenomenon is
unique to the SHR and is dependent upon the presence of
hypertension, we have extended our observations to isolated
kidneys from prehypertensive DS rats and their salt—resistant
DR counterparts. Kidneys from prehypertensive DS rats man-
ifested modestly—exaggerated glomerular responses to the cal-
cium channel blockers, verapamil and nitrendipine, compared
to DR kidneys. In contrast to the SHR kidney which manifested
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increased sodium excretion in proportion to the GFR after
verapamil [4], DS kidney sodium excretion did not increase in
response to an increased GFR.
Methods
We isolated kidneys from 24 male DS and 22 male DR rats
(obtained from Dr. J. Iwai, Brookhaven National Laboratory,
Upton, Long Island, New York, USA) which had been main-
tained on a 0.3% NaC1 chow diet. At the time of study, the age
of the DS rats averaged 15 2 weeks (mean sEM) and that of
the DR rats averaged 14 2 weeks. DS rat weight averaged 412
11 g and DR rat weight averaged 411 10 g. During mactin
anesthesia (100 mg/kg i.p.), the carotid or femoral mean arterial
pressure was measured directly utilizing a pressure transducer
system (Harvard Instruments, Millis, Massachusetts, USA).
Our kidney isolation and perfusion procedures have been
described previously [51. Briefly, after kidneys were flushed and
isolated without ischemia, they were perfused at 37°C with an
oxygenated cell—free, modified Krebs Henseleit perfusate. Ox-
ygenation was accomplished by equilibration with 95% 02/5%
C02; this also stabilized the perfusate pH at 7.40 to 7.42. The
perfusate contained electrolytes, glucose, inulin, and amino
acids in amounts reported previously [5]. Bovine serum albu-
min fraction V, (Pentex—Miles, Kankakee, Illinois, USA) had
been purified previously with a hemodialyzer.
The hydraulic pressure of the perfusion system was moni-
tored continuously and the renal perfusion pressure was main-
tained at 105 mm Hg by adjusting the perfusate flow rate. The
renal perfusion pressure was determined by taking into account
and subtracting off the pressure decrease imposed by the
precalibrated needle cannulating the renal artery. After an
initial 20 to 30 minutes of perfusion, urine and perfusate
specimens were obtained for two control periods of 5 to 10
minutes each.
Sufficient norepinephrine then was added to the perfusate to
increase the RVR by 50% over the control value. Simulta-
neously, an infusion of norepinephrine dissolved in perfusate
was begun and adjusted to a rate sufficient to maintain the
increased RVR for the duration of the experiment. After
stabilization, urine and perfusate specimens were obtained for
two more periods of five minutes each during norepinephrine
infusion. Subsequently, either verapamil (0.01 mM) or nitrend-
ipine (0.01 mM) was added to the perfusate, and similar speci-
mens for a final experimental phase were obtained. In separate
time control experiments, DS and DR kidneys were perfused
similarly except that norepinephrine was omitted from the
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perfusate vehicle; nitrendipine or verapamil was added after the
same time interval had elapsed.
Norepinephrine (Parke—Davis, Morris Plains, New Jersey)
and verapamil were dissolved directly in perfusate. Nitrendi-
pine was dissolved in a small amount of polyethylene glycol
insufficient to affect kidney function in preliminary experi-
ments, and was protected from light exposure. Urine volumes
were estimated gravimetrically. Inulin was analyzed chemically
by a resorcinol method; its clearance provided an estimate of
the GFR. Sodium was determined by flame photometry. RVR
was computed as the quotient of the renal perfusion pressure
divided by perfusate flow. Data were not factored by kidney
weights; DS kidney weight averaged 1.83 0.05 g compared to
DR kidney weight of 1.70 0.05 g (P = 0.31).
Statistical comparisons of experimental with control values
were done by the paired t-test. The significance of differences
among different experimental groups was determined by an
analysis of variance. When significant overall differences ex-
isted (P < 0.05), all possible comparisons were made utilizing
the Newman—Keuls multiple comparison procedure at a signif-
icance level of P < 0.05. When fewer comparisons were made,
we used the Bonferroni procedure. Additionally, a multivariate
analysis of variance with repeated measures was utilized in
order to compare the influence of DahI status (DS vs. DR),
choice of calcium antagonist (verapamil vs. nitrendipine) and
presence of agonist (norepinephrine vs. vehicle) on sequential
and nonsequential changes in GFR, RYR, and sodium excre-
tion. These analyses were performed using Systat' programs
(Systat, Inc., Evanston, Illinois, USA) on an IBM AT micro-
computer. Data are expressed as mean SEM throughout.
Results
During anesthesia, mean arterial pressure of DS rats aver-
aged 129 4 mm Hg and that of DR rats averaged 114 3 mm
Hg (P = 0.007). The results from experiments with DS and DR
kidneys receiving norepinephrine followed by either nitrendi-
pine or verapamil are summarized in Figure 1 and in Table 1.
DS kidney RYR was more sensitive to norepinephnne than DR
kidney RVR (P = 0.006). In order to increase RVR by 50%, DS
kidneys required a norepinephrine bolus of 57 4 ng/ml
followed by the constant infusion of 120 10 ng/minute into 65
ml of recirculating perfusate. DR kidneys required 77 6 ng/ml
followed by 157 19 ng/minute. The decreases in GFR of DS
and DR kidneys were not affected differentially by norepineph-
rine (P = 0.50).
Calcium channel blockers then were added while norepineph-
rine infusion was continued. Verapamil both decreased the
RVR and increased the GFR to a greater extent than nitrendi-
pine (P = 0.026 and 0.004, respectively) when compared to
values during norepinephrine infusion alone. Compared to the
initial control phase, both verapamil and nitrendipine increased
the GFR of DS and DR kidneys (Table 1). Only when both
groups were pooled was the increase in GFR significantly
greater in DS than in DR kidneys (Table 2). By analysis of
variance of the effects of Dahl status and the particular calcium
antagonist utilized, the GFR increased significantly more in DS
than DR kidneys (P = 0.033) and verapamil increased the GFR
more than nitrendipine (P =0.018). The increments in GFR for
the DS kidneys were approximately double those of the DR
kidneys, and increments in GFR for verapamil treated kidneys
Fig. 1. Glomerular response to calcium antagonist addition to perfus-
ate of isolated norepinephrine (NE) vasoconstricted DS (•) and DR ()
kidneys. GFR increased more in DS than DR kidneys and verapamil
increased GFR more than nitrendipine. Asterisks indicate significant
differences from control (CON) phase (P < 0.05). These calcium
antagonists did not increase GFR in the absence of norepinephrine.
Nitrendipine and verapamil affected renal vascular resistance similarly.
were approximately double those of corresponding nitrendi-
pine—treated kidneys (Table 2). Despite these differential influ-
ences on changes in GFR imposed by Dahl status and by the
particular calcium antagonist, RVR and renal perfusate flow
(RPF) changes (Table 2) were unaffected by Dahl status (P =
0.37) and choice of calcium antagonist (P = 0.12).
Although the calcium channel blockers collectively increased
DS kidney GFR in an exaggerated fashion, parallel changes in
DS kidney absolute and fractional sodium excretion did not
occur (Table 2). Baseline values for sodium excretion did not
differ significantly, but diverged in succeeding phases with DR
tending to exceed DS, especially during the calcium antagonist
phase (Table 1). Absolute sodium excretion increased in both
groups of DR kidneys, but not in DS kidneys. Likewise, DS
fractional sodium excretion (FENa) was less than DR FENa
during the calcium antagonist phase (P 0.001). Although
nitrendipine accentuated differences between DS and DR so-
dium excretion and FENa more than verapamil, the two agents
did not affect changes in these parameters from control differ-
entially (P = 0.9 and 0.7, respectively). Comparisons of
changes between the control and calcium antagonist phases
indicated that there were significantly greater increases in both
sodium excretion and FENa for DR than DS kidneys (Table 2).
DS kidneys did not increase either parameter in spite of their
large GFR increases.
We also examined the effects of verapamil and nitrendipine
without norepinephnne in time control experiments (Table 3).
Those studies encompassed the same time intervals as the
experiments with norepinephrine. Neither calcium antagonist
alone produced a significant increase in GFR or absolute
sodium excretion in the absence of nonrepinephrine. Analysis
*
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Table 1. Calcium antagonist superimposition upon norepinephrine
GFR p1/mm Na Excretion pEq/min FENa x 100% RVR mm Hg/mi• min'
CON NE NE+CA CON NE NE+CA CON NE NE+CA CON NE NE+CA
Nitrendipine
DS kidneys (N = 8)
466 58 992 2.43 O.42a 1.90 3.79 8.36 1.73a 2.21 339a 2.57a
94 27 135 0.58 0.15 0.40 0.61 3.46 0.39 0.10 0.15 0.14
DR kidneys (N 7)
647 2l7 864 3.75 1.69a 5.66a 4.36 4.71 4.98 1.94 3.09a 2.33a
±52 ±53 ±90 ±0.75 ±0.57 ±1.01 ±0.74 ±0.94 ±0.88 ±0.08 ±0.17 ±0.13
P 0.128 0.015 0.460 0.181 0.040 0.003 0.560 0.359 0.004 0.051 0.407 0.240
Verapamil
DS kidneys (N = 6)
504 41a 1545a 1.57 0.24a 1.69 2.78 5.21 l.03a 2.31 3.48a 2.53a
±83 ±9 ±157 ±0.56 ±0.07 ±0.26 ±0.47 ±1.88 ±0.23 ±0.19 ±0.31 ±0.20
DR kidneys (N = 5)
612 172a 1187a 2.35 0.64a 3.58a 3.30 4.95 2.65 2.27 3.7P 2.58a
± 118 ± 88 ± 172 ± 0.63 ± 0.12 ± 1.08 ± 0.84 ± 1.66 ± 0.96 ± 0.11 ± 0.26 ± 0.11
P 0.462 0.136
Overall DS vs. DR Corn
0.160
parisons (bo
0.378
th drugs)
0.013
0.015
0.097
0.001
0.269
0.267
0.921
0.373
0.106
0.001
0.884
0.176
0.439
0.916
0.8250.447 P 80.003 0.168 0.108
Abbreviations are: GFR, glornerular filtration rate; FENa, fractional sodium excretion; RVR, renal vascular resistance; CON, control; NE,
norepinephrine infusion; NE + CA, calcium antagonist superimposed on norepinephrine.
a Significant difference from control (P < 0.05). P values are DS vs. DR comparisons. Values are means ± SEM.
Table 2. Changes in renal hemodynamics and sodium excretion
during calcium antagonist superimposition upon norepinephrine
A GFR
pJ/min
A Na Excretion
p.Eq/min
A FeNa
%
A RPF
mi/mm
Nitrendipine
DS kidneys (N = 8)
+526 —0.53 —2.06 —6.2
± 154 ± 0.33 ± 0.27 ± 0.9
DR kidneys (N = 7)
+217 + 1.90 +0.62 —8.3
± 104 ± 0.42 ± 0.27 ± 1.8
P 0.065 <0.001 <0.001 0.148
Veraparnil
DS kidneys (N = 6)
+1040 +0.13 —1.22 —3.8
± 210 ± 0.42 ± 0.29 ± 0.9
DR kidneys (N = 5)
+575 + 1.24 —0.65 —5.4
± 215 ± 0.57 ± 1.25 ± 1.3
P 0.079
Overall DS vs. DR corn
0.072
parisons (both drugs)
0.319
0.002
0.1640.085 P0.026 <0.001
Each A value is value during final phase (calcium antagonist plus
neorepinephrine) minus control. Data are means ± SEM. P values are
DS vs. DR comparisons.
of variance of all data (experimental and time control data
combined) utilizing the presence or absence of norepinephrine
as a variate indicated that the presence of norepinephrine was
required in order to elicit an increased GFR (P < 0.001) and
sodium excretion (P = 0.002), along with a residual increase in
RVR (P < 0.001), after the addition of calcium antagonists.
Examination of the changes between the control and calcium
antagonist phases for all of the parameters of Table 3 indicated
that there were no significant intergroup differences, with P
ranging from 0.06 to 0.42. Additional time control experiments
utilizing norepinephrine alone, without calcium antagonists,
indicated a stable degree of norepinephrine induced vasocon-
striction over the duration of these studies (Table 4).
Discussion
When verapamil or nitrendipine was superimposed upon
norepinephrine infusion, the GFR of DS kidneys increased in a
mildly exaggerated fashion compared to that of DR kidneys.
Therefore, the results correspond to those from our previous
experiments employing kidneys from normal Sprague—Dawley
rats [5]. Those kidneys exhibited variable GFR responsiveness
when verapamil or diltiazem was superimposed upon norepi-
nephrine.
Although RVR was not affected differentially by verapamil
and nitrendipine at equal concentrations, the GFR increased to
a greater extent after the superimposition of verapamil than
after superimposition of nitrendipine. This may have reflected
different pharmacological properties of these agents. Nitrendi-
pine and other dihydropyridine derivatives are thought to block
transmembrane calcium fluxes rather specifically [61, but
verapamil may exert additional influences on cell metabolism
[7]. Dihydropyridine derivatives such as nitrendipine appear to
bind specifically to slowly—inactivating vascular calcium chan-
nels while in the inactivated state [8]. The fact that both agents,
taken together, manifested a qualitatively similar differential
effect on DS kidney GFR is consistent with the possibility that
an abnormality of cell calcium regulation exists in the DS rat
kidney.
Despite greater increases in DS kidney GFR following cal-
cium antagonist superimposition, DS sodium excretion re-
mained unchanged and FENa decreased. Several previous stud-
ies have indicated that isolated DS kidneys exhibit "memory"
with respect to sodium reabsorption, in that they manifest a
blunted natriuresis over a range of perfusion pressures com-
pared to DR kidneys [9—11]. In the present work in which a
constant perfusion pressure of 105 mm Hg was maintained, the
superimposition of verapamil or nitrendipine upon norepineph-
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Table 3. Time control experiments without norepinephrine
GFR pi/min Na excretion pEqirnin FEa)< 100 % RVR mm Hg/mi min'
CON-i CON-2 CA CON-I CON-2 CA CON-I CON-2 CA CON-i CON-2 CA
Nitrendipine
DS kidneys (N = 5)
622 529 725 2.55 2.56 2.66 3.42 3.89 2.82 1.97 1.97 1.99
83 119 96 0.44 0.50 0.53 0.84 0.68 0.32 0.16 0.18 0.19
DR kidneys (N = 5)
798 641 819 6.59 6.32 6.24 6.16 7.02 5.89 1.70 1.64 1.65
93 114 33 i.37 1.39 1.34 0.99 1.22 1.33 0.12 0.13 0.12
P 0.131 0.476 0.803 0.012 0.027 0.025 0.042 0.030 0.028 0.239 0.198 0.215
Verapamii
DS kidneys (N = 5)
593 578 563 3.31 2.99 3.00 3.46 3.62 3.77 1.87 1.82 1.80
95 77 102 0.99 0.85 0.86 0.80 0.79 0.85 0.05 0.05 0.05
DR kidneys (N = 5)
551 430 376 4.12 3.93 3.78 5.85 6.94 7.60 1.67 1.61 1.59
70 50 40 0.70 0.68 0.57 0.99 1.14 1.16 0.08 0.09 0.09
P 0.2600.010 0.126 0.523 0.663 0.470 0.099 0.043 0.028 0.073 0.070 0.083
Abbreviations are: CON-i corresponds to control phase; CON-2 corresponds to norepinephrine phase; CA corresponds to final phase.
aP < 0.05 compared to CON-i. Values are means SEM. P values are DS vs. DR comparisons
Table 4. Norepinephrine time controls without calcium antagonists
GFR pi/min RVRmm Hg/m1 min'
CON NE-i NE-2 CON NE-i NE-2
DS kidneys (N =
DR kidneys (N =
3)
3)
567 85
675 86
36 13
404 110
37 i5
4i4 111
2.43a 0.03
i.40 0.03
3.54 0.06
2.i3 0.05
3.38 0.15
2.11 0.07
NE-i and NE-2 are sequential phases empioying norepinephrine infusion without calcium antagonists.
a Significant difference from NE-i phase (P < 0.05)
rine accentuated the differences between DS and DR natriuretic
capacities (Tables 1, 2). The enhancing effect of these calcium
antagonists on the GFR of DS kidneys was not accompanied by
parailel changes in their sodium excretion. Although absolute
sodium reabsorption increased in all four groups of kidneys as
the GFR increased, the increase was greater for DS then for DR
kidneys (P < 0.001). These results indicate that calcium antag-
onists failed to correct sluggish, DS kidney sodium—excretion.
Verapamil or nitrendipine superimposition upon norepineph-
rine did not return the RVR to control values. If residual
increases in RVR of approximately 15% reflected increased
mesangial contractility, a parallel increase in GFR would seem
improbable. The residual increase in RVR instead may have
reflected a persistent component of norepinephrine—induced
efferent arteriolar—vasoconstriction during calcium channel—
blocker superimposition [12]. However, our results do not
allow an assessment of the mechanisms underlying changes in
glomerular dynamics.
Several investigators have shown that the DS rat kidney
achieves a very blunted natriuresis in response to an increasing
perfusion pressure [9—11]. Our results indicate that large in-
creases in the GFR do not increase DS kidney sodium excretion
in the absence of an increase in perfusion pressure. In contrast,
DR kidney sodium excretion increased briskly under similar
circumstances. The modest increases in DS kidney sodium
excretion accompanying stepwise elevation of the renal perfu-
sion pressure during other isolated perfused Dahl kidney exper-
iments probably can be attributed to hydraulic pressure in-
creases alone, and not to pressure induced increases in the GFR
per Se. To the extent that the isolated kidney preparation
reflects events in the living animal, the renal perfusion pressure
appears to be fundamentally involved in achieving DS rat
sodium balance. A report employing lithium as a marker for
proximal tubule sodium—reabsorption has suggested that the
latter is accentuated in the DS rat kidney [13]. If so, it would be
interesting to determine whether DS proximal tubule reabsorp-
tion is less sensitive to hydraulic pressure changes than is
proximal reabsorption in DR rats.
Sodium chloride—induced hypercalciuria has been reported in
DS rats [14] and in DOCA-salt hypertensive rats [15]. More
recently, Umemura et al have reported a depressed renal
adenylate cyclase response to parathyroid hormone (PTH) in
the Rapp variant of the DS rat and have postulated that this
defective response to PTH may be the cause of DS rat
hypercalciuria [16]. Although unproven, one can speculate that
calcium depletion could play a role in the pathogenesis of
hypertension [1]. In addition, because most currently available
data suggest that renal sodium transport varies inversely with
the cytosol calcium [17—19], it is possible that calcium depletion
Calcium antagonists and Dahi rat kidney 945
may contribute to avid sodium reabsorption by the DS rat
kidney.
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